Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study

BACKGROUND: Azilsartan is an angiotensin II receptor blocker indicated for the treatment of adult hypertension. A previous single-dose study suggested that azilsartan may also be a promising agent for paediatric hypertension. However, the long-term safety and efficacy of azilsartan in children have...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Shuichi, Nishiyama, Yuya, Sugiura, Kenkichi, Enya, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930870/
https://www.ncbi.nlm.nih.gov/pubmed/34837606
http://dx.doi.org/10.1007/s10157-021-02159-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930870/
https://www.ncbi.nlm.nih.gov/pubmed/34837606
http://dx.doi.org/10.1007/s10157-021-02159-9

Ejemplares similares